Brian Dobosh
Impact in
-
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Immunotherapy and Immune Responses
-
- Neonatal Respiratory Health Research
- Cystic Fibrosis Research Advances
Papers in
-
- COVID-19 Clinical Research Studies 6
- SARS-CoV-2 and COVID-19 Research 3
- SARS-CoV-2 detection and testing 2
-
- RNA Interference and Gene Delivery 3
- CRISPR and Genetic Engineering 2
- Co-authors
- Rabindra Tirouvanziam (14 shared papers)Camilla Margaroli (6 shared papers)Amit Gaggar (3 shared papers)Gabriel Rezonzew (1 shared paper)Tarek Abdalla (1 shared paper)Liliana Viera (1 shared paper)Charitharth Vivek Lal (1 shared paper)Tomasz Szul (1 shared paper)
- Journals
- Scientific Reports (2 papers)International Journal of Molecular Sciences (2 papers)Molecular Therapy (1 paper)Science Translational Medicine (1 paper)ImmunoHorizons (1 paper)
- Partner nations
- United StatesSouth AfricaBrazil
In The Last Decade
Brian Dobosh
16 papers receiving 636 citations
Brian Dobosh's Hit Papers
Peers
Comparison fields: 5 of 77
- Immunology 211
- Pulmonary and Respiratory Medicine 196
- Cancer Research 90
- Molecular Biology 402
- Infectious Diseases 90
Countries citing papers authored by Brian Dobosh
This map shows the geographic impact of Brian Dobosh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Dobosh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Dobosh more than expected).
Fields of papers citing papers by Brian Dobosh
This network shows the impact of papers produced by Brian Dobosh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Dobosh. The network helps show where Brian Dobosh may publish in the future.
Co-authors
The 25 scholars most cited alongside Brian Dobosh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Activated PMN Exosomes: Pathogenic Entities Causing Matrix Destruction and Disease in the Lung Hit paper breakdown → | 2019 | 336 |
| 2 | 2019 | 65 | |
| 3 | 2019 | 55 | |
| 4 | 2018 | 53 | |
| 5 | 2019 | 40 | |
| 6 | 2021 | 30 | |
| 7 | 2022 | 19 | |
| 8 | 2020 | 17 | |
| 9 | 2022 | 11 | |
| 10 | 2022 | 5 | |
| 11 | 2024 | 5 | |
| 12 | 2024 | 3 | |
| 13 | 2021 | 2 | |
| 14 | 2021 | 1 | |
| 15 | 2020 | 1 | |
| 16 | 2024 | 1 | |
| 17 | 2025 | 0 |
About Brian Dobosh
Brian Dobosh is a scholar working on Infectious Diseases, Molecular Biology, Pulmonary and Respiratory Medicine, Immunology and Epidemiology, having authored 17 papers that have together received 644 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (6 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers), RNA Interference and Gene Delivery (3 papers), Cystic Fibrosis Research Advances (2 papers), Respiratory Support and Mechanisms (2 papers), SARS-CoV-2 detection and testing (2 papers) and CRISPR and Genetic Engineering (2 papers). The work is most often cited by research in Immunology (211 citations), Pulmonary and Respiratory Medicine (196 citations), Cancer Research (90 citations), Molecular Biology (402 citations) and Infectious Diseases (90 citations). Brian Dobosh has collaborated with scholars based in United States, South Africa and Brazil. Frequent co-authors include Rabindra Tirouvanziam, Camilla Margaroli, Amit Gaggar, Gabriel Rezonzew, Tarek Abdalla, Liliana Viera, Charitharth Vivek Lal, Tomasz Szul, Robert W. King and J. Michael Wells. Their work appears in journals such as Scientific Reports, International Journal of Molecular Sciences, Molecular Therapy, Science Translational Medicine and ImmunoHorizons.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.